Contract

Provision of Oncotype DX Breast Recurrence ScoreTM Assay

  • BELFAST HEALTH AND SOCIAL CARE TRUST

F03: Contract award notice

Notice identifier: 2023/S 000-018358

Procurement identifier (OCID): ocds-h6vhtk-03d509

Published 28 June 2023, 10:42am



Section one: Contracting authority

one.1) Name and addresses

BELFAST HEALTH AND SOCIAL CARE TRUST

LISBURN ROAD

BELFAST

BT97AB

Contact

Norma Moore

Email

norma.moore@belfasttrust.hscni.net

Country

United Kingdom

Region code

UKN06 - Belfast

Justification for not providing organisation identifier

Not on any register

Internet address(es)

Main address

https://belfasttrust.hscni.net/

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Provision of Oncotype DX Breast Recurrence ScoreTM Assay

Reference number

DAC11239

two.1.2) Main CPV code

  • 33000000 - Medical equipments, pharmaceuticals and personal care products

two.1.3) Type of contract

Supplies

two.1.4) Short description

Procurement of the Provision of Oncotype DX Breast Recurrence ScoreTM Assay

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £450,000

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKN - Northern Ireland
Main site or place of performance

Belfast Health and Social Care Trust Laboratories

two.2.4) Description of the procurement

The procurement for the Provision of Oncotype DX Breast Recurrence ScoreTM Assay

two.2.5) Award criteria

Price

two.2.11) Information about options

Options: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The services can be provided only by a particular economic operator for the following reason:
    • absence of competition for technical reasons

Explanation:

No reasonable alternative exists for this procurement Provision of Oncotype DX Breast Recurrence Score Assay is available from only one economic operator and is essential for service delivery and patient care for breast cancer patients in Northern Ireland, the absence of competition is not the result of an artificial narrowing down of the parameters of this procurement.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.1) Previous publication concerning this procedure

Notice number: 2023/S 000-016415


Section five. Award of contract

Contract No

DAC11239

Title

Provision of Oncotype DX Breast Recurrence ScoreTM Assay

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

26 June 2023

five.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Exact Sciences UK Ltd

100 New Bridge Street

London

EC4V 6JA

Country

United Kingdom

NUTS code
  • UKI - London
Companies House

07484560

Internet address

https://www.exactsciences.com/uk

The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £450,000

Total value of the contract/lot: £450,000


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

Belfast Health and Social Care Trust

Belfast

BT8 8BH

Country

United Kingdom

Internet address

https://belfasttrust.hscni.net/